MetaCure Implant For Type 2 Diabetes: Overseas Trials To Wrap Up By 2012

MetaCure plans to wrap up three overseas trials by the end of 2012 for its DIAMOND electrostimulator implant for type 2 diabetes in obese patients and will begin a pivotal U.S. trial within the next couple of years to support a PMA submission for type 2 diabetes.

More from Archive

More from Medtech Insight